VP, Hematology Oncology Clinical Development

Regulatory Jobs; Upper Providence (Delaware County); Híbrido; USD 341.000 - 568.000; Jornada completa

Ventajas ofrecidas por este puesto de trabajo

Annual bonus

Health care benefits

Paid holidays

Descripción de la vacante

GSK is seeking a VP, Oncology Clinical Development Disease Area Head to oversee end‑to‑end clinical development across the hematology/oncology portfolio, guiding strategy and execution from early studies to launch.

You will partner with Research, Translational Medicine, Medical Affairs, and Regulatory to accelerate asset development, shape development strategies, and drive cross‑functional decision‑making in a global, matrix environment.

Formación

• Medical degree with board certification or eligibility in oncology.
• At least 10 years clinical development experience leading global clinical development programs in hematology and oncology in the pharmaceutical industry, academia, or combined.
• Senior clinical and scientific leadership in early‑ and late‑phase oncology drug development, including FTIH through registrational trials and launch readiness.
• Proven track record designing and delivering late‑phase clinical trials and regulatory submissions.
• Experience leading geographically dispersed teams and complex multi‑stakeholder programs.

Responsabilidades

• Accountable for end‑to‑end clinical development of oncology assets from first‑in‑human (FTIH) studies through proof‑of‑concept studies, registrational trials, regulatory approval, and initial market launch, ensuring scientific rigor, speed, and quality of execution.
• Shape and drive the scientific and clinical development strategy for assigned disease areas and assets, aligned with Oncology Tumor Team strategy and broader Oncology portfolio priorities.
• Ensure deep integration of clinical, and disease‑area expertise into preclinical and translational research activities to optimize asset positioning, biomarker strategy, and development strategy and decisions.
• Evaluate, champion, and enable the use of novel approaches (e.g., AI/ML, innovative trial designs, external and real‑world data sources) where they add clear scientific, operational, or decision‑making value to clinical development.
• Provide program‑level oversight and leadership, while ensuring connectedness both cross‑functionally and across assets, maintaining visibility to progress, risks, dependencies, and trade‑offs across the Oncology portfolio.
• Lead scientific advisory boards and other external engagements to inform asset strategy, competitive positioning, and portfolio decisions, incorporating emerging science and external expert insight.
• Co‑lead asset development with matrix leadership partners, driving alignment across research, development, and commercialization planning, and ensuring cohesive execution against shared objectives.

Conocimientos

Business Acumen

Clinical Data Interpretation

Clinical Trial Designs

Digital Fluency

Drug Development

Regulatory Affairs

Executive Presence

Hematology Oncology

Innovative Leadership

Line Management

Scientific Presentations

Strategic Direction

Educación

Medical degree with board certification or eligibility in oncology

Descripción del empleo

GSK is seeking a VP, Oncology Clinical Development Disease Area Head to oversee end‑to‑end clinical development across the hematology/oncology portfolio, guiding strategy and execution from early studies to launch.

You will partner with Research, Translational Medicine, Medical Affairs, and Regulatory to accelerate asset development, shape development strategies, and drive cross‑functional decision‑making in a global, matrix environment.